国家: 以色列
语言: 英文
来源: Ministry of Health
CINACALCET AS HYDROCHLORIDE
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD
H05BX01
FILM COATED TABLETS
CINACALCET AS HYDROCHLORIDE 30 MG
PER OS
Required
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL
CINACALCET
Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet -Trima may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with:• parathyroid carcinoma.• primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.
2020-08-31
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986 This medicine is dispensed with a doctor’s prescription only CINACALCET-TRIMA 30 MG, 60 MG, 90 MG FILM-COATED TABLETS ACTIVE INGREDIENT: Each tablet contains: 30 mg, 60 mg, 90 mg cinacalcet (as hydrochloride). For information about inactive ingredients and allergens in this medicine, please see section 6 ‘Additional information’. READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. This leaflet contains concise information about this medicine. If you have any further questions, consult your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if it seems to you that their medical condition is similar to yours. THIS MEDICINE IS NOT INTENDED FOR CHILDREN UNDER 18 YEARS OLD. 1. WHAT IS THIS MEDICINE INTENDED FOR? This medicine is used to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products. to reduce hypercalcemia (high levels of calcium in the blood) in patients with parathyroid cancer. to reduce high levels of calcium in the blood (hypercalcemia) in patients with primary hyperparathyroidism when removal of the parathyroid gland is not possible. THERAPEUTIC GROUP: This medicine regulates the levels of calcium and has anti-parathyroid activity. It is used to treat diseases caused by impaired function of the organs called parathyroid glands. . BEFORE USING THIS MEDICINE: DO NOT USE THIS MEDICINE IF: You are sensitive (allergic) to the active ingredient cinacalcet or to any of the other ingredients in this medicine (listed in section 6). SPECIAL WARNINGS ABOUT USING THIS MEDICINE: Consult a doctor, pharmacist, or nurse before you take Cinacalcet-Trima. BEFORE YOU START TREATMENT WITH CINACALCET- TRIMA, TELL YOUR DOCTOR IF: you have or have ever had: epileptic seizures (convulsions or spasms). The risk of having these seizures is higher in patients who have had seizu 阅读完整的文件